{"title":"A comparative study of standard cytogenetic evaluation and molecular karyotyping for products of conception.","authors":"Leanne Baxter, Nandini Adayapalam","doi":"10.1097/PDM.0b013e31829265ab","DOIUrl":null,"url":null,"abstract":"<p><p>Genetic analysis of fetal tissue provides valuable information regarding the underlying causes of miscarriage. However, current analysis techniques are limited and expensive. This trial compared a molecular multiplex, bead-based suspension array, KaryoLite Bacs on Beads, with conventional tissue culture and G-banded karyotype techniques. A 92% overall success rate was achieved. This method detected a cryptic deletion of a 7q subtelomeric region, a case of 25% mosaic trisomy 14, and 2 unbalanced subtelomeric rearrangements due to familial balanced translocations. Twenty (24%) of the 83 samples analyzed, that failed to yield a cytogenetic result due to culture failure, were successfully assayed using the suspension array. Genomic imbalances including trisomies and subtelomeric deletions were detected in 3 cases (15%) of previously failed cases. This method is limited by its inability to detect polyploidy, which is significant in first trimester loss. However, this can be readily overcome by prescreening using florescent in situ hybridization. Data indicates that KaryoLite BoBs molecular testing is superior to conventional cytogenetic evaluation in several key areas, including success rate (95% vs. 76%, for this study group), cost, turnaround time (2 vs. up to 28 d), and subjective result interpretation. </p>","PeriodicalId":11235,"journal":{"name":"Diagnostic Molecular Pathology","volume":"22 4","pages":"228-35"},"PeriodicalIF":0.0000,"publicationDate":"2013-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/PDM.0b013e31829265ab","citationCount":"10","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diagnostic Molecular Pathology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/PDM.0b013e31829265ab","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 10
Abstract
Genetic analysis of fetal tissue provides valuable information regarding the underlying causes of miscarriage. However, current analysis techniques are limited and expensive. This trial compared a molecular multiplex, bead-based suspension array, KaryoLite Bacs on Beads, with conventional tissue culture and G-banded karyotype techniques. A 92% overall success rate was achieved. This method detected a cryptic deletion of a 7q subtelomeric region, a case of 25% mosaic trisomy 14, and 2 unbalanced subtelomeric rearrangements due to familial balanced translocations. Twenty (24%) of the 83 samples analyzed, that failed to yield a cytogenetic result due to culture failure, were successfully assayed using the suspension array. Genomic imbalances including trisomies and subtelomeric deletions were detected in 3 cases (15%) of previously failed cases. This method is limited by its inability to detect polyploidy, which is significant in first trimester loss. However, this can be readily overcome by prescreening using florescent in situ hybridization. Data indicates that KaryoLite BoBs molecular testing is superior to conventional cytogenetic evaluation in several key areas, including success rate (95% vs. 76%, for this study group), cost, turnaround time (2 vs. up to 28 d), and subjective result interpretation.
胎儿组织的遗传分析为流产的潜在原因提供了有价值的信息。然而,目前的分析技术是有限的和昂贵的。本试验比较了分子复合,珠基悬浮阵列,KaryoLite Bacs on Beads,与传统的组织培养和g带核型技术。总成功率达到92%。该方法检测到7q亚端粒区域的隐性缺失,1例25%的14号镶嵌三体,以及2例由于家族平衡易位而导致的亚端粒重排不平衡。在分析的83个样品中,有20个(24%)由于培养失败而未能产生细胞遗传学结果,使用悬浮阵列成功地进行了检测。在先前失败的病例中,有3例(15%)检测到基因组失衡,包括三体和亚端粒缺失。这种方法是有限的,它无法检测多倍体,这是显著的早期妊娠损失。然而,这可以很容易地克服预先筛选使用荧光原位杂交。数据表明,KaryoLite BoBs分子检测在几个关键领域优于传统的细胞遗传学评估,包括成功率(95% vs. 76%,该研究组)、成本、周转时间(2 vs.最长28 d)和主观结果解释。
期刊介绍:
Diagnostic Molecular Pathology focuses on providing clinical and academic pathologists with coverage of the latest molecular technologies, timely reviews of established techniques, and papers on the applications of these methods to all aspects of surgical pathology and laboratory medicine. It publishes original, peer-reviewed contributions on molecular probes for diagnosis, such as tumor suppressor genes, oncogenes, the polymerase chain reaction (PCR), and in situ hybridization. Articles demonstrate how these highly sensitive techniques can be applied for more accurate diagnosis.